INTRODUCTION
============

Rho small GTPases including RhoA, Rac1, and Cdc42 regulate multiple aspects of neuronal development including cell migration, cell polarity, axon growth and pathfinding, and dendritic elaboration ([@B7]; [@B2]). They function as molecular switches that shift between an active GTP-bound state and an inactive GDP-bound state ([@B5]). The active forms of Rho small GTPases bind their specific effector molecules to regulate F-actin and microtubule dynamics and gene expression ([@B5]). While guanine nucleotide exchange factors (GEFs) function as positive regulators of Rho small GTPases by stimulating the exchange of bound GDP for GTP, GTPase activating proteins (GAPs) negatively regulate Rho small GTPases by enhancing the intrinsic GTPase activity of Rho proteins ([@B7]; [@B8]; [@B5]).

As suggested by the defined roles of Rho GTPases in the nervous system, various *Drosophila* RhoGAP proteins have been implicated in neuronal morphogenesis. For example, p190 RhoGAP has been shown to maintain axon branch stability in mushroom body neurons by inactivating RhoA ([@B1]). In addition, genetic and biochemical interaction experiments suggest that CrossGAP/Vilse mediates Robo-mediated axon repulsion by the local inactivation of Rac ([@B6]; [@B4]). Recently, the Cdc42-selective GAP dRich has been shown to promote synaptic growth at the neuromuscular junction (NMJ) ([@B9]), further demonstrating the significance of RhoGAP in neuronal development.

Although the *Drosophila* genome contains at least 20 predicted RhoGAPs ([@B4]), many of them have not been characterized in the nervous system. In this study, we identified RhoGAP68F as a RhoA-selective GAP that is highly expressed in the embryonic central nervous system (CNS). In addition, we show that overexpression of RhoGAP68F in motor neurons causes synaptic overgrowth at the larval NMJ. These results raise the possibility that RhoGAP68F may play an essential role for neuronal development by inactivating RhoA.

MATERIALS AND METHODS
=====================

Cell culture
------------

HEK293 and NIH3T3 cells were cultured in Dulbecco\'s modified Eagle\'s medium (DMEM) containing 10% fetal bovine serum and antibiotics. These cells were transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer\'s instructions. To induce actin structural changes, NIH3T3 cells were serum-starved for 12 hr and treated for 10 min with 20 ng/ml lysophosphatidic acid (LPA) (Sigma), 10 ng/ml PDGF (Upstate Biotechnology), or 100 ng/ml Bradykinin (Sigma) before fixation.

Plasmids
--------

The full-length cDNA clone for *RhoGAP68F* was obtained from the *Drosophila* Genomics Resource Center. The entire coding region of *RhoGAP68F* was amplified by PCR using appropriate primers and introduced into *pcDNA-HA* (Invitrogen) for mammalian expression. The *RhoGAP68F- R315A* point mutation was made using the QuikChange Multi kit (Stratagene). Plasmids for Myc- RhoA, Rac1, and Cdc42 were previously described ([@B10]).

RNA *in situ* hybridization
---------------------------

RNA *in situ* hybridization on whole mount embryos was performed as previously described ([@B16]). The entire *RhoGAP68F* cDNA was cloned into pBluscript (Stratagene). The resulting plasmid was linearized and used for the generation of a digoxygenin (DIG)-UTP-labeled *RhoGAP68F* RNA probe by run-off transcription. Embryos were dechorionated and fixed in PBS containing 5% formaldehyde. Fixed embryos were hybridized with DIG-labeled riboprobes at 62℃ and then incubated with alkaline phosphatase-conjugated anti-DIG antibody for 1 hr at room temperature. The alkaline phosphatase reaction was performed using 5-bromo-4-chloro-indoyl phosphate (BCIP) and nitro blue tetrazolium (NBT). The embryos were mounted in Permount (Fisher Scientific).

Rho-GTP pull-down assay
-----------------------

Inactivation of Rho proteins by RhoGAP68F was analyzed using the EZ-detect Rho, Rac, or Cdc42 activation kit (Pierce), as previously described ([@B10]). Briefly, HEK293 cells transiently expressing *pCMV-Myc-RhoA*, *Rac1*, or *Cdc42* and *pcDNA-HA-RhoGAP68F* or *pcDNA-HA-RhoGAP68F-R315A* were lysed in 25 mM Tris (pH 7.5), 150 mM NaCl, 5 mM MgCl~2~, 1% NP-40, 1 mM DTT, and 5% glycerol. Cell lysates were clarified by centrifugation at 13,000× g for 10 min. Equal volumes of lysates were then incubated at 4℃ for 1 hr with glutathione-Sepharose 4B-bound GST-Rhotekin-PBD (for RhoA-GTP) or GST-PAK1-PBD (for Rac1-GTP and Cdc42-GTP) fusion protein. The beads were washed four times with the lysis buffer and boiled in SDS sample buffer. The amount of GTP-bound Myc-RhoA, Rac1, or Cdc42 was determined by western blotting using an anti-Myc antibody (Cell Signaling). The total amounts of Rho proteins from cell lysates were determined by western blotting using an anti-Myc or anti-HA (Roche) antibody.

Fly stock and genetics
----------------------

The wild-type strain used in this study was *w*^1118^. A transgenic line carrying *UAS-RhoGAP68F* was obtained in the *w*^1118^ background using standard protocols ([@B13]). *Elav-GeneSwitch-GAL4* ([@B12]) was used to drive *UAS-RhoGAP68F* expression in postembryonic neurons.

Immunohistochemistry
--------------------

NIH3T3 cells were transfected with a plasmid encoding HA-RhoGAP68F or HA-RhoGAP68F-R315A. Immunostaining of transfected cells was performed as previously described ([@B10]). Filamentous actin structures were visualized using rhodamine-conjugated phalloidin (Invitrogen) at 1:250.

Larval body wall muscles were dissected from wandering third-instar larvae in Ca^2+^-free HL3 saline ([@B15]) and fixed in 4% formaldehyde in PBS for 30 min. Fixed muscles were washed with PBT (PBS, 0.1% Triton X-100) and incubated with goat anti-HRP conjugated with FITC (Jackson ImmunoResearch, 1:200) for 1 hr at room temperature. Image acquisition and morphological quantification were performed as previously described ([@B11]).

RESULTS AND DISCUSSION
======================

Identification of RhoGAP68F, a RhoA-specific GAP that is highly expressed in the nervous system
-----------------------------------------------------------------------------------------------

The *Drosophila* genome contains at least 20 RhoGAPs for the Rho family ([@B4]); however, their role(s) in the developing nervous system are still poorly understood. As an initial step to address this issue, we searched by RNA *in situ* hybridization on whole-mount embryos for previously uncharacterized RhoGAP genes expressed in the central nerves system (CNS), and found that the annotated gene *RhoGAP68F* (CG6811) fulfills the criterion. A high level of *RhoGAP68F* message was uniformly detected in early stage embryos (e.g. stage 5; [Fig. 1A](#F1){ref-type="fig"}), suggesting a significant maternal contribution ([Fig. 1A](#F1){ref-type="fig"}). *RhoGAP68F* expression was restricted to brain lobes and the ventral nerve cord by stage 13 ([Fig. 1B](#F1){ref-type="fig"}). The enrichment of *RhoGAP68F* expression in the embryonic CNS was maintained until the end of embryogenesis ([Fig. 1C](#F1){ref-type="fig"}).

The Flybase database predicts that *RhoGAP68F* encodes a 476-amino acid protein consisting of an N-terminal Sec14 domain (amino acids 95-241) and a C-terminal RhoGAP domain (amino acids 289-461). This domain organization is identical to the human p50RhoGAP protein ([Fig. 2A](#F2){ref-type="fig"}). Overall, the RhoGAP68F protein displays 37% identity and 60% similarity to its human counterpart at the amino acid level. A previous work has shown that RhoGAP68F has GAP activity toward human RhoA *in vitro* ([@B14]). To examine the *in vivo* substrate of the RhoGAP68F, HEK293 cells were transiently transfected with *pCMV-Myc-RhoA*, *Rac1*, or *Cdc42* along with either *pcDNA-HA* or *pcDNA-HA-RhoGAP68F*, and the amounts of active, GTP-bound Rho GTPases in the lysates of the transfectants were determined by p21-binding domain (PBD) pull-down assays (see Materials and Methods). As shown in [Fig. 2B](#F2){ref-type="fig"}, expression of HA-RhoGAP68F efficiently removed GTP-RhoA ([Fig. 2B](#F2){ref-type="fig"}). However, the level of GTP-Rac1 or GTP-Cdc42 was not changed by HA-RhoGAP68F expression ([Fig. 2B](#F2){ref-type="fig"}), suggesting that RhoGAP68F acts as a RhoA-selective GAP *in vivo*. RhoGAP68F contains the arginine finger at position 315, which is conserved in RhoGAP-family proteins. A RhoGAP68F mutant carrying a substitution mutation of this amino acid (RhoGAP68F-R315A) did not effectively reduce the level of GTP-RhoA ([Fig. 2B](#F2){ref-type="fig"}).

RhoGAP68F inhibits LPA-induced stress fiber formation mediated by RhoA
----------------------------------------------------------------------

Rho small GTPases are well known for their specific effects on the organization of the actin cytoskeleton in fibroblasts: RhoA produces stress fibers associated with focal adhesion complexes, Rac1 induces lamellipodia and membrane ruffles, and Cdc42 triggers the formation of filopodia or microspikes ([@B3]). To further characterize the substrate specificity of RhoGAP68F, we examined the effect of RhoGAP68F overexpression on the actin cytoskeleton in cultured cells. NIH3T3 cells were transfected with HA-tagged RhoGAP68F and then stained with rhodamine-conjugated phalloidin to visualize actin filaments. As shown in [Fig. 3](#F3){ref-type="fig"}, expression of RhoGAP68F inhibited lysophosphatidic acid (LPA)-induced stress fiber formation mediated by RhoA ([Fig. 3A](#F3){ref-type="fig"}). However, RhoGAP68F expression had no effect on either PDGF-induced membrane ruffling mediated by Rac1 or Bradykinin-induced filopodia formation mediated by Cdc42. Finally, LPA-induced stress fiber formation was not significantly affected by expression of the R315A GAP-deficient mutant ([Fig. 3B](#F3){ref-type="fig"}). These results suggest that RhoGAP68F acts as a RhoA-selective GAP in NIH3T3 cells.

Neuronal overexpression of RhoGAP68F induces synaptic overgrowth at the Drosophila larval neuromuscular junction
----------------------------------------------------------------------------------------------------------------

Because *RhoGAP68F* was found highly in the embryonic CNS, we wished to determine the role of RhoGAP68F in synapse development. To investigate this, we expressed exogenous *RhoGAP68F* in all neurons and then examined synaptic growth at the larval neuromuscular junction (NMJ). Overexpression of RhoGAPs at embryonic stages could cause defects in axon development ([@B1]), complicating analysis of its effect on synaptic growth. Therefore, we overexpressed *UAS-RhoGAP68F* in all neurons from the early first instar stage, when synapse formation between motor axons and target muscles is already finished, by employing the inducible neuronal GAL4 driver *Elav-GS-GAL4* system, in which gene expression is induced only by the addition of the progesterone analog RU486 ([@B12]). When raised on the food containing RU486 throughout larval development, third instar *Elav-GS-GAL4/UAS-RhoGAP68F* animals displayed excessive NMJ growth ([Fig. 4A, B](#F4){ref-type="fig"}). To quantify this phenotype, we measured bouton number and branch number at NMJ 6/7 in abdominal segment 2 ([Fig. 4C](#F4){ref-type="fig"}). Bouton number was increased by 42% in *Elav-GS-GAL4/UAS-RhoGAP68F* larvae compared with *Elav-GS-GAL4*/+ controls (169.4±5.3 versus 120.0±2.1; mean±SEM; p\<0.001). In addition, the number of NMJ branches was increased by 86% (29.7±0.8 versus 16.0±0.7; p\<0.001), supporting a novel role for RhoGAP68F in the regulation of synaptic growth.

In summary, we provide evidence that RhoGAP68F functions as a negative regulator of RhoA signaling *in vivo*. This conclusion is consistent with a previous finding that RhoGAP68F acts as a RhoA-selective GAP *in vitro* ([@B14]). Although RhoGAP68F is shown to regulate morphogenetic events during gastrulation of the embryo ([@B14]), it has not been addressed whether they also regulates neuronal morphogenesis. In this study, we have shown that *RhoGAP68F* is highly expressed in the nervous system and that presynaptic overexpression of RhoGAP68F affects NMJ growth, raising the possibility that RhoA signaling and its regulators may play a key role in synaptic growth and plasticity during development.
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![Expression of *RhoGAP68F* transcript during embryo development. *In situ* hybridization on whole-mount embryos was performed to using *RhoGAP68F* antisense RNA probe. All embryos are anterior to the left, and dorsal is up. (A) Lateral view of a stage 5 embryo. *RhoGAP68F* mRNA was broadly detected throughout the entire embryo, indicating its maternal loading. (B) Lateral view of a stage 13 embryo. *RhoGAP68F* mRNA was abundant in the developing CNS. (C) Lateral view of a stage 16 embryo. High levels of *RhoGAP68F* expression were maintained in the CNS. (D) Lateral view of a stage 16 embryo. A *RhoGAP68F* sense probe shows no signal. Scale bar, 20 µm.](en-20-29-g001){#F1}

![RhoGAP68F is a RhoA-selective GAP. (A) Domain structure of RhoGAP68F and human p50RhoGAP. The percent amino acid identity between the homologs is indicated. The point mutation R315A in the GAP domain of RhoGAP68F is marked by asterisk. (B) RhoGAP68F inactivates RhoA but not Rac1 or Cdc42 in cells. HEK293 cells were co-transfected with a plasmid encoding Myc-RhoA, Rac1, or Cdc42 along with a plasmid encoding HA, HA-RhoGAP68F, or HA-RhoGAP68F-R315A. Following transfection, GTP-loaded RhoA, Rac1, and Cdc42 were precipitated with GST fusion PBDs of Rhotekin (for RhoA) and PAK1 (for Rac1 and Cdc42). The levels of GTP-bound GTPases in the precipitates were determined by western blot analysis using an anti-Myc antibody (upper panel). Levels of HA and Myc proteins in the cell lysates were determined by western blot analysis using anti-HA (middle panel) and anti-Myc (lower panel) antibodies, respectively.](en-20-29-g002){#F2}

![Effect of RhoGAP68F on actin cytoskeletal changes induced by LPA, PDGF, and Bradykinin in NIH3T3 cells. NIH3T3 cells were transfected with a plasmid expressing either HA-RhoGAP68F (A) or HA-RhoGAP68F-R315A (B). After a 12 hr serum withdrawal, cells were incubated with 20 ng/ml LPA for RhoA activation, 10 ng/ml PDGF for Rac1 activation, or 100 ng/ml Bradykinin for Cdc42 activation. Cells were stained with anti-HA and rhodamine-conjugated phalloidin to visualize HA-RhoGAP68F (green) and filamentous actin (red), respectively. Scale bar, 20 µm.](en-20-29-g003){#F3}

![Neuronal overexpression of RhoGAP68F causes synaptic overgrowth at the larval NMJ. (A, B) Confocal images of third instar NMJs 6/7 labeled with anti-HRP are shown for *Elav-GS-GAL4*/+ and *Elav-GS-GAL4/UAS-RhoGAP68F* larvae. Note that presynaptic overexpression of RhoGAP68F causes NMJ overgrowth. Scale bar, 50 µm. (C) Quantification of total bouton number and branch number at NMJs 6/7 in *Elav-GS-GAL4*/+ and *Elav-GS-GAL4/UAS-RhoGAP68F* third instar larvae. Data are mean±SEM. The numbers of NMJs analyzed are indicated inside bars. Statistically significant differences are indicated by asterisk (p\<0.001).](en-20-29-g004){#F4}
